Lastly, the induction of CHS at the tumor site could cause the infiltration of hapten-specific T-regs, which could potentially release IL-10 to suppress effector T-cells [141] or elicit CD8+ T-cell exhaustion by expression of CTLA-4 [118]. This evidence concerns the gene CD8A and neoplasm.